Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Switching between reference adalimumab and biosimilars in chronic immune-mediated inflammatory diseases: A systematic literature review.
García-Beloso N, Altabás-González I, Samartín-Ucha M, Gayoso-Rey M, De Castro-Parga ML, Salgado-Barreira Á, Cibeira-Badia A, Piñeiro-Corrales MG, González-Vilas D, Pego-Reigosa JM, Martínez-López de Castro N. García-Beloso N, et al. Br J Clin Pharmacol. 2022 Feb;88(4):1529-1550. doi: 10.1111/bcp.15101. Epub 2021 Nov 2. Br J Clin Pharmacol. 2022. PMID: 34622969 Free article. Review.
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C; EMBODY Investigator Group. Clowse ME, et al. Arthritis Rheumatol. 2017 Feb;69(2):362-375. doi: 10.1002/art.39856. Arthritis Rheumatol. 2017. PMID: 27598855 Free PMC article. Clinical Trial.
Adherence to biological therapies in patients with chronic inflammatory arthropathies.
Martínez-López de Castro N, Álvarez-Payero M, Samartín-Ucha M, Martín-Vila A, Piñeiro-Corrales G, Pego Reigosa JM; Working Group IRIDIS (Rheumatology, Immunology and Immune-Mediated Diseases); Rodríguez-Rodríguez M, Melero-González RB, Maceiras-Pan FJ. Martínez-López de Castro N, et al. Farm Hosp. 2019 Jul 1;43(4):134-139. doi: 10.7399/fh.11183. Farm Hosp. 2019. PMID: 31276446 English.
Biological therapy safety in chronic inflammatory arthropathy patients.
Martínez-López-de-Castro N, Álvarez-Payero M, Samartín-Ucha M, Martín-Vila A, Piñeiro-Corrales G, Rodríguez-Rodríguez M, Maceiras-Pan FJ, Melero-González RB, Pego-Reigosa JM. Martínez-López-de-Castro N, et al. Eur J Rheumatol. 2020 Jan 2:1-7. doi: 10.5152/eurjrheum.2019.19074. Online ahead of print. Eur J Rheumatol. 2020. PMID: 31922476 Free article.
Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study.
Samartín-Ucha M, Pego-Reigosa JM, Álvarez-Payero M, Martin-Vila A, Pineiro-Corrales G, Rodriguez-Rodriguez M, Melero-Gonzalez RB, Maceiras-Pan F, Martinez-Reglero C, Mrtinez-Lopez de Castro N. Samartín-Ucha M, et al. Eur J Hosp Pharm. 2021 Nov;28(Suppl 2):e47-e50. doi: 10.1136/ejhpharm-2019-002133. Epub 2020 May 13. Eur J Hosp Pharm. 2021. PMID: 32404382 Free PMC article.
Biological therapy safety in chronic inflammatory arthropathy patients.
Martínez-López-de-Castro N, Álvarez-Payero M, Samartín-Ucha M, Martín-Vila A, Piñeiro-Corrales G, Rodríguez-Rodríguez M, Maceiras-Pan FJ, Melero-González RB, Pego-Reigosa JM. Martínez-López-de-Castro N, et al. Eur J Rheumatol. 2020 Apr;7(2):53-59. doi: 10.5152/eurjrheum.2019.19123. Epub 2020 Jan 2. Eur J Rheumatol. 2020. PMID: 32644925 Free PMC article.
Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study.
Martínez-López-de-Castro N, Álvarez-Payero M, Samartín-Ucha M, Martínez-Reglero C, Martín-Vila A, Rodríguez-Rodríguez M, Piñeiro-Corrales G, Maceiras-Pan JF, Melero-González RB, Pego-Reigosa JM. Martínez-López-de-Castro N, et al. Clin Exp Rheumatol. 2021 Jul-Aug;39(4):736-745. doi: 10.55563/clinexprheumatol/x1h3xi. Epub 2020 Sep 3. Clin Exp Rheumatol. 2021. PMID: 32896255 Free article.
Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
Tejera Segura B, Altabás González I, Rúa-Figueroa I, Pérez Veiga N, Del Campo Pérez V, Olivé-Marqués A, Galindo M, Calvo J, Ovalles-Bonilla JG, Fernández-Nebro A, Menor-Almagro R, Tomero E, Del Val Del Amo N, Uriarte Isacelaya E, Martínez-Taboada VM, Andreu JL, Boteanu A, Narváez J, Movasat A, Montilla C, Senabre Gallego JM, Hernández-Cruz B, Andrés M, Salgado E, Freire M, Machín García S, Moriano C, Expósito L, Pérez Velásquez C, Velloso-Feijoo ML, Cacheda AP, Lozano-Rivas N, Bonilla G, Arévalo M, Jiménez I, Quevedo-Vila V, Manero-Ruiz FJ, García de la Peña Lefebvre P, Vázquez-Rodríguez TR, Ibañez-Rua J, Cobo-Ibañez T, Pego-Reigosa JM. Tejera Segura B, et al. Rheumatology (Oxford). 2021 Nov 3;60(11):5329-5336. doi: 10.1093/rheumatology/keab401. Rheumatology (Oxford). 2021. PMID: 33950249
Analysis of the implementation of an innovative IT solution to improve waiting times, communication with primary care and efficiency in Rheumatology.
Pego-Reigosa JM, Peña-Gil C, Rodríguez-Lorenzo D, Altabás-González I, Pérez-Gómez N, Guzmán-Castro JH, Varela-Gestoso R, Díaz-Lambarri R, González-Carreró-López A, Míguez-Senra O, Bóveda-Fontán J, Charle-Crespo Á, Caramés-Casal FJ, Barbazán-Álvarez C, Hernández-Rodríguez Í, Maceiras-Pan F, Rodríguez-López M, Melero-González R, Rodríguez-Fernández JB. Pego-Reigosa JM, et al. BMC Health Serv Res. 2022 Jan 12;22(1):60. doi: 10.1186/s12913-021-07455-4. BMC Health Serv Res. 2022. PMID: 35022061 Free PMC article.
116 results